MBOT - Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company | Benzinga
BRAINTREE, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ:MBOT), developer of the innovative LIBERTY® Robotic Surgical System, today announces that the United States District Court for the Southern District of New York, approved Microbot's motion for summary judgment and dismissed with prejudice the previously announced Section 10(b) counterclaim brought by defendant as against Microbot in the action titled Microbot Medical Inc., Plaintiff v. Joseph Mona, Defendant.
In its Memorandum Decision and Order, the Court adopted in full the Magistrate Judge's Report and Recommendation, which had recommended that the Court grant Microbot's motion for summary judgment and dismiss defendant's counterclaim with prejudice.
In its ruling, in part, the Court held that the defendant failed to raise a triable issue of fact in support of his claim.
Microbot previously announced that a judgment in the action against defendant and in favor of Microbot in the amount of $484,614.30 was entered, and no appeal was filed. As the counterclaim has now been dismissed, the Company is now seeking to enforce the judgment as against defendant.
About Microbot Medical
Microbot Medical Inc. ...